CELLDEMIC (Seqirus Pty Ltd)
Product name
CELLDEMIC
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
210 (255 working days)
Active ingredients
Influenza virus haemagglutinin
Registration type
NCE/ NBE
Indication
CELLDEMIC® is indicated for active immunisation against the H5 subtype of Influenza A virus in persons from 6 months of age and older.